Search research articles
Contact Us
Filters
Showing results (31-40 of 444) with videos related to
Page
of 45
Sort By:
American Journal of Hypertension
|
October 1, 1995
Organ protection and optimal blood pressure control
P A Meredith
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
November 1, 1994
New FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responses
P A Meredith
Expert Opinion on Investigational Drugs
|
July 5, 2005
Lercanidipine: a novel lipophilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivity
P A Meredith
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1993
Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 3: Safety, efficacy, tolerability and duration of action
P A Meredith
American Journal of Ophthalmology
|
June 30, 1998
Choroidal melanoma: diagnosis and management
T A Meredith
Journal of Cardiovascular Pharmacology
|
May 30, 1998
How to evaluate the duration of blood pressure control: the trough:peak ratio and 24-hour monitoring
P A Meredith
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 20, 2005
Angiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effect
Peter A Meredith
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
April 17, 1999
Posttraumatic endophthalmitis
T A Meredith
Blood Pressure. Supplement
|
October 31, 2001
Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockers
P A Meredith
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
December 24, 1997
Epiretinal membrane delamination with a diamond knife
T A Meredith
Page
of 45
Search research articles
Search
Showing results (31-40 of 444) with videos related to
Sort By:
Page
of 45
American Journal of Hypertension
|
October 1, 1995
Organ protection and optimal blood pressure control
P A Meredith
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
November 1, 1994
New FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responses
P A Meredith
Expert Opinion on Investigational Drugs
|
July 5, 2005
Lercanidipine: a novel lipophilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivity
P A Meredith
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1993
Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 3: Safety, efficacy, tolerability and duration of action
P A Meredith
American Journal of Ophthalmology
|
June 30, 1998
Choroidal melanoma: diagnosis and management
T A Meredith
Journal of Cardiovascular Pharmacology
|
May 30, 1998
How to evaluate the duration of blood pressure control: the trough:peak ratio and 24-hour monitoring
P A Meredith
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 20, 2005
Angiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effect
Peter A Meredith
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
April 17, 1999
Posttraumatic endophthalmitis
T A Meredith
Blood Pressure. Supplement
|
October 31, 2001
Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockers
P A Meredith
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
December 24, 1997
Epiretinal membrane delamination with a diamond knife
T A Meredith
Page
of 45